Aldicarb Immunotoxicity: Functional Analysis of Cell-Mediated Immunity and Quantitation of Lymphocyte Subpopulations

Aldicarb Immunotoxicity: Functional Analysis of Cell-MediatedImmunity and Quantitation of Lymphocyte Subpopulations. THOMAS,P., RATAJCZAK, H., DEMETRAL, D., HAGEN, K., AND BARON, R. (1990).Fundam. Appl. Toxicol. 15, 221–230. Adult female B6C3F1mice received distilled water only or water containing 1.0,10, or 100 ppb of aldicarb daily for 34 days. The target concentrationof aldicarb present in the 100 ppb dosing solution was analyticallyverified. To further develop an immune profile of this compound,following aldicarb exposure, the ability of splenic naturalkiller cells and specifically sensitized cytotoxic T-lymphocytesto lyse YAC-1 lymphoma and P815 tumor cells, respectively, wasevaluated. To supplement the functional assays, the impact ofaldicarb exposure on the percentages and absolute numbers oftotal T-cells, T-suppressor, T-helper, and B-cells was evaluated.The absence of statistically significant effects on any of theseparameters supports earlier reports that aldicarb does not resultin adverse effects on the immune system of mice.     

A JOINT PROBLEM DRINKING CLINIC: THE KING'S COLLEGE AND MAUDSLEY HOSPITALS INITIATIVE

We describe the establishment of a joint alcohol misuse clinic,staffed by both a psychiatrist and a physician, in a LondonTeaching Hospital providing general as well as specialist medicalservices. The demographic and medicopsychiatric problems ofthe first 100 referrals (60% attendance rate) are described.The clinic provides an assessment and re-education role formost patients referred with alcohol misuse problems: the needfor specialist alcohol treatment facilities, especially forin-patients, remains essential. In addition, the clinic providesa valuable training and research resource.     

The Noninvasive Mouse Ear Swelling Assay: II. Testing the Contact Sensitizing Potency of Fragrances

The Noninvasive Mouse Ear Swelling Assay. I. Refinements forDetecting Weak Contact Sensitizers. THORNE, P. S., HAWK, C,KAUSZEWSKI, S. D., AND GUINEY, P. D. (1991). Fundam. Appl. Toxicol.17, 790–806. The noninvasive mouse ear swelling assay(MESA) is a model for delayed-type hypersensitivity that holdspromise as a testing protocol for allergic contact dermatitis(ACD). The MESA employs only topical sensitization on the abdomenand does not use injections, adjuvants, anesthesia, occlusion,or disruption of the stratum comeum. Five days after induction,the ears are challenged topically and ear swelling measurementstaken at 24,48, and 72 hr indicate the extent of ACD. In thisstudy, refinements of the assay were explored in BALB/cBy miceusing dinitrofluorobenzene (DNFB) and dinitrochlorobenzene (DNCB).A complete dose-response curve was developed for DNFB and thedose which sensitized half the mice in a group (SD50, 0.001%,w/v) was used to test noninvasive enhancement protocols. Severaltriple-dose protocols tested produced no increase in responsivenessand daily dosing showed a trend toward tolerance induction yielding20% positive responses. Dietary vitamin A supplementation produceda dramatic enhancement of the responses: ear thickness increasewas doubled and the SD50 sensitized 94 to 100% of the mice inthe vitamin A groups. We conclude that the MESA allowed identificationof ACD potency for known sensitizers at very low concentrationswhich do not produce ACD with other techniques. The importanceof dose-response studies for avoiding the high-dose reduced-responseregion was also shown. Based on the observation that the vitaminA-augmented MESA was considerably more sensitive than with regularfeed, a companion study (P. S. THORNE, C. HAWK, S. D. KALISZEWSKI,P. D. GUINEY, Fundam. Appl. Tox. 17, 807–820, 1991) presentstests of the enhancements to the MESA developed in this work,using weak sensitizers and complex mixtures.     

Disclosure,Apology, and Offer Programs: Stakeholders’ Views of Barriers to and Strategies for Broad Implementation

Context: The Disclosure, Apology, and Offer (DA&O) model, a response to patient injuries caused by medical care, is an innovative approach receiving national attention for its early success as an alternative to the existing inherently adversarial, inefficient, and inequitable medical liability system. Examples of DA&O programs, however, are few. Methods: Through key informant interviews, we investigated the potential for more widespread implementation of this model by provider organizations and liability insurers, defining barriers to implementation and strategies for overcoming them. Our study focused on Massachusetts, but we also explored themes that are broadly generalizable to other states. Findings: We found strong support for the DA&O model among key stakeholders, who cited its benefits for both the liability system and patient safety. The respondents did not perceive any insurmountable barriers to broad implementation, and they identified strategies that could be pursued relatively quickly. Such solutions would permit a range of organizations to implement the model without legislative hurdles. Conclusions: Although more data are needed about the outcomes of DA&O programs, the model holds considerable promise for transforming the current approach to medical liability and patient safety.     

The use of a ‘bleach‐etch‐seal’ deproteinization technique on MIH affected enamel

International Journal of Paediatric Dentistry 2012; 22: 427–434 Aims. To ascertain whether deproteinization pretreatment of molar‐incisor hypomineralization (MIH) enamel affects resin sealant infiltration. Design. Thirty one extracted MIH teeth were divided into three sections and randomly allocated into the Control (etch and FS), Treatment 1 (5% NaOCl, etched and fissure sealed), and Treatment 2 (5% NaOCl and fissure sealed with no etch) groups. Two hundred seventy nine sealant tag/enamel grade observations were recorded by scanning electron microscopy. Results. Control and Treatment 1 were similar in their outcomes, and Treatment 2 was markedly different. There was no statistical evidence to suggest that there was any difference between Treatment 1 and the Control Treatment (95% CI, 0.52, 1.51; P = 0.6). There was a marked difference between Treatment 2 and the Control Treatment (95% CI, 0.07, 0.25; P < 0.001). All treatments also demonstrated a high‐predicted probability of obtaining ‘poor’ sealant tags (Control = 47%, Treatment 1 = 49%, and Treatment 2 = 40%). Conclusions. The findings suggest that there was no significant difference in the tag quality between the conventional technique (Control) and the ‘bleach‐etch‐seal’ technique (Treatment 1). There was no benefit in pre‐treating with NaOCl alone (without etch) before sealing. This research also showed that there was a high‐predicted probability of obtaining ‘poor’ sealant tags in MIH enamel, regardless of which of the three treatments was used.     

Who can give ‘spiritual care’? The management of spiritually sensitive interactions between nurses and patients

kevern p. (2012) Journal of Nursing Management  20, 981–989
Who can give ‘spiritual care’? The management of spiritually sensitive interactions between nurses and patients Aims This article considers the purpose of contemporary ‘spiritual care’ in order to help managers make informed decisions about its appropriate delivery in a clinical context. Background Although there are national policies in place concerning spiritual care, surveys indicate that nurses are reluctant to engage with the spiritual needs of patients. Evaluation A consideration of the character of spiritual care indicates the need to take account of the context of contemporary Western society. A model drawn from the social psychology of religion is used to analyse the different types of nurse–patient interaction available in the provision of spiritual care. Key Issues Although religious and spiritual commitments can vary widely, they are subject to the same pressures in a secular and pluralist social context. This enables some general guidelines to be developed. Conclusions Effective spiritual care requires a consideration of both the patient’s and the nurse’s implicit and explicit religious commitments. Implications for nursing management Nurse managers need to take account of the personal commitments of nurses when directing them to offer spiritual care. This article offers a diagnostic tool for deploying nurses in an appropriate way.     

Gastric and oesophageal emptying in insulin-dependent diabetes mellitus

Abstract Gastric emptying of a digestible solid and liquid meal and oesophageal emptying of a solid bolus were measured with scintigraphic techniques in 45 randomly selected insulin-dependent diabetics and in 22 control subjects. In the diabetics, the relationships between oesophageal emptying, gastric emptying, age, duration of diabetes mellitus, upper gastrointestinal symptoms, glycaemic control and the complications, autonomic neuropathy, peripheral neuropathy and retinopathy were examined. The lag period before solid food left the stomach was not significantly different in diabetics compared with control subjects, but the percentage retention of solid food at 100 min was greater ( P < 0.001) in the diabetic subjects. Both the early phase (percentage retention at 10 min) and the 50% emptying time for liquid gastric emptying were delayed ( P < 0.001) in the diabetic subjects. Of the diabetics, 58% had delayed gastric emptying of either the solid and/or the liquid meal; oesophageal emptying was delayed in 42%. Upper gastrointestinal symptoms correlated poorly with both gastric and oesophageal emptying. Oesophageal emptying, solid gastric emptying and the liquid 50% emptying time correlated with the severity of autonomic nerve dysfunction ( P < 0.05). The early phase of liquid emptying (retention at 10 min) was significantly slower ( P < 0.05) in patients with mean plasma glucose concentrations of > 15 mmol/l during the gastric emptying test and the lag period for solid emptying correlated with both the glycosylated haemoglobin and mean plasma glucose concentrations.     

Responses to Norepinephrine of Normal and "Ischemic" Canine Purkinje Fibers are Consistent with Activation of Different α1-Receptor Subtypes

α₁-Receptor Subtype Stimulation of Purkinje Fibers. Introduction: Previously we found that WB4101 (WB) 10^-7 M competitively blocks three α₁-adrenergic receptor-effector responses: the increase in normal automaticity occurring in Purkinje fibers (PF) at high membrane potentials: the increase in abnormal automaticity occurring in PF at depolarized membrane potentials; and the prolongation of PF action potential duration. These observations are consistent with two different hypotheses: (1) WB blocks a single α₁-receptor subtype, which subserves different effector pathways; and (2) WB blocks different receptor subtypes, eacb of which subserves an independent patbway. The aim of this study was to test both hypotheses. Methods and Results: We used standard microelectrode techniques to study the concentration-dependent actions of three α₁-adrenoreceptor blockers (WB (α_1A?α_1D], 5-methylurapidil [5-MU] [α_1A, ?α_1D], and UK52,046 [nonselective]) on norepinephrine (NK) effects in normal PF and in PF depolarized with a simulated ischemic solution ([K⁺]_o= 10 mM; pO₂ < 20 mmHg; pH 6.8; maximum diastolic potential -60 ± 1 mV). In normally polarized PF, concentration-dependent actions of all blockers on both the positive cbronotropic response and the prolongation of action potential duration completely coincide. In contrast, the response to NE of abnormal automaticity in “ischemic” PF differs from normals: there is a bigh sensitivity to WB and 5-MU and no response to UK52,046. Conclusions: (1) A single receptor subtype appears responsible for botb the α₁-induced prolongation of repolarization and the positive chronotropic effect in normal PF. (2) Two different receptor subtypes may be responsible for the α₁-induced effects on automaticity in normal and ischemic fibers. It is likely that the latter one is α_1A, and that consideration of antiarrhythmic therapy with α₁-adrenergic blockers should focus on this subtype as a potential target.